LUNG

Pulmonx Corporation (LUNG) is an innovative medical technology company based in Redwood City, California, dedicated to advancing the treatment of chronic obstructive pulmonary disease (COPD) through its minimally invasive solutions. The company has gained recognition for its flagship product, the Zephyr® Endobronchial Valve, which significantly improves lung function and enhances the quality of life for patients while minimizing procedural risks. With a robust portfolio and a focus on delivering superior clinical outcomes, Pulmonx is well-positioned to lead the respiratory disease treatment market, targeting a substantial and growing population of individuals affected by COPD.